Bid Publish Date
01-Jan-2025, 3:13 pm
Bid End Date
22-Jan-2025, 4:00 pm
Location
Progress
Quantity
20400
Category
TAB LEVICETRAM 500 MG
Bid Type
Two Packet Bid
Public procurement opportunity for Directorate Of Health Services Kashmir TAB OXICARBAMAZPINE, SYP OXICARBAMAZPINE, SYP BACLOFEN, TAB BRIVACETRAM 100MG, TAB BRIVACETRAM 75 MG, TAB BRIVACETRAM 50MG, TAB LEVICETRAM 750 MG, TAB LEVICETRAM 500 MG, TAB LEVICETRAM 250 MG, TAB DIVALPROX 500 MG, SYP PHENOBARBITONE 50MG, TAB PHENOBARBITONE 50MG, SYP LEVICETRAM 500 MG, TAB CLOBA 5MG, TAB CLOBA 10MG, SYP CARNISUE, TAB CLONITRIL 0 POINT 25 MG, TAB CLONITRIL 0 POINT 50 MG in BUDGAM, JAMMU & KASHMIR. Quantity: 20400 issued by. Submission Deadline: 22-01-2025 16: 00: 00. View full details and respond.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
TAB OXICARBAMAZPINE , SYP OXICARBAMAZPINE , SYP BACLOFEN , TAB BRIVACETRAM 100MG , TAB BRIVACETRAM 75 MG , TAB BRIVACETRAM 50MG , TAB LEVICETRAM 750 MG , TAB LEVICETRAM 500 MG , TAB LEVICETRAM 250 MG , TAB DIVALPROX 500 MG , SYP PHENOBARBITONE 50MG , TAB PHENOBARBITONE 50MG , SYP LEVICETRAM 500 MG , TAB CLOBA 5MG , TAB CLOBA 10MG , SYP CARNISUE , TAB CLONITRIL 0 POINT 25 MG , TAB CLONITRIL 0 POINT 50 MG
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
TAB OXICARBAMAZPINE
TAB OXICARBAMAZPINE
SYP OXICARBAMAZPINE
SYP OXICARBAMAZPINE
SYP BACLOFEN
SYP BACLOFEN
TAB BRIVACETRAM 100MG
TAB BRIVACETRAM 100MG
TAB BRIVACETRAM 75 MG
TAB BRIVACETRAM 75 MG
TAB BRIVACETRAM 50MG
TAB BRIVACETRAM 50MG
TAB LEVICETRAM 750 MG
TAB LEVICETRAM 750 MG
TAB LEVICETRAM 500 MG
TAB LEVICETRAM 500 MG
TAB LEVICETRAM 250 MG
TAB LEVICETRAM 250 MG
TAB DIVALPROX 500 MG
TAB DIVALPROX 500 MG
SYP PHENOBARBITONE 50MG
SYP PHENOBARBITONE 50MG
TAB PHENOBARBITONE 50MG
TAB PHENOBARBITONE 50MG
SYP LEVICETRAM 500 MG
SYP LEVICETRAM 500 MG
TAB CLOBA 5MG
TAB CLOBA 5MG
TAB CLOBA 10MG
TAB CLOBA 10MG
SYP CARNISUE
SYP CARNISUE
TAB CLONITRIL 0 POINT 25 MG
TAB CLONITRIL 0 POINT 25 MG
TAB CLONITRIL 0 POINT 50 MG
TAB CLONITRIL 0 POINT 50 MG
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | TAB OXICARBAMAZPINE | TAB OXICARBAMAZPINE | 1,000 | tabs | dhnew2 | 15 | |
| 2 | SYP OXICARBAMAZPINE | SYP OXICARBAMAZPINE | 1,000 | nos | dhnew2 | 15 | |
| 3 | SYP BACLOFEN | SYP BACLOFEN | 500 | nos | dhnew2 | 15 | |
| 4 | TAB BRIVACETRAM 100MG | TAB BRIVACETRAM 100MG | 2,000 | tabs | dhnew2 | 15 | |
| 5 | TAB BRIVACETRAM 75 MG | TAB BRIVACETRAM 75 MG | 2,000 | tabs | dhnew2 | 15 | |
| 6 | TAB BRIVACETRAM 50MG | TAB BRIVACETRAM 50MG | 2,000 | tabs | dhnew2 | 15 | |
| 7 | TAB LEVICETRAM 750 MG | TAB LEVICETRAM 750 MG | 3,000 | tabs | dhnew2 | 15 | |
| 8 | TAB LEVICETRAM 500 MG | TAB LEVICETRAM 500 MG | 3,000 | tabs | dhnew2 | 15 | |
| 9 | TAB LEVICETRAM 250 MG | TAB LEVICETRAM 250 MG | 1,500 | tabs | dhnew2 | 15 | |
| 10 | TAB DIVALPROX 500 MG | TAB DIVALPROX 500 MG | 200 | tabs | dhnew2 | 15 | |
| 11 | SYP PHENOBARBITONE 50MG | SYP PHENOBARBITONE 50MG | 200 | nos | dhnew2 | 15 | |
| 12 | TAB PHENOBARBITONE 50MG | TAB PHENOBARBITONE 50MG | 500 | tabs | dhnew2 | 15 | |
| 13 | SYP LEVICETRAM 500 MG | SYP LEVICETRAM 500 MG | 1,000 | nos | dhnew2 | 15 | |
| 14 | TAB CLOBA 5MG | TAB CLOBA 5MG | 1,000 | tabs | dhnew2 | 15 | |
| 15 | TAB CLOBA 10MG | TAB CLOBA 10MG | 1,000 | tabs | dhnew2 | 15 | |
| 16 | SYP CARNISUE | SYP CARNISUE | 300 | nos | dhnew2 | 15 | |
| 17 | TAB CLONITRIL 0 POINT 25 MG | TAB CLONITRIL 0 POINT 25 MG | 100 | tabs | dhnew2 | 15 | |
| 18 | TAB CLONITRIL 0 POINT 50 MG | TAB CLONITRIL 0 POINT 50 MG | 100 | tabs | dhnew2 | 15 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | CAPS & SCALPELS PHARMA PRIVATE LIMITED Under PMA | - | 20-01-2025 17:56:34 | |
| 2 | HITECH HEALTHCARE AND TECHNOLOGIES Under PMA | - | 19-01-2025 20:06:05 | |
| 3 | KASHMIR PHARMA & SURGICALS Under PMA | - | 21-01-2025 14:17:01 | |
| 4 | SALIHAH PHARMACEUTICAL DISTRIBUTOR Under PMA | - | 19-01-2025 20:29:46 | |
| 5 | SUNIL PHARMACY Under PMA | - | 22-01-2025 15:22:46 |
| Rank | Seller | Price | Item |
|---|---|---|---|
| L1 | HITECH HEALTHCARE AND TECHNOLOGIES(MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : TAB OXICARBAMAZPINE,SYP OXICARBAMAZPINE,SYP BACLOFEN,TAB BRIVACETRAM 100MG,TAB BRIVACETRAM 75 MG,TA | |
| L2 | SALIHAH PHARMACEUTICAL DISTRIBUTOR (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : TAB OXICARBAMAZPINE,SYP OXICARBAMAZPINE,SYP BACLOFEN,TAB BRIVACETRAM 100MG,TAB BRIVACETRAM 75 MG,TA | |
| L3 | CAPS & SCALPELS PHARMA PRIVATE LIMITED (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : TAB OXICARBAMAZPINE,SYP OXICARBAMAZPINE,SYP BACLOFEN,TAB BRIVACETRAM 100MG,TAB BRIVACETRAM 75 MG,TA | |
| L4 | SUNIL PHARMACY (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : TAB OXICARBAMAZPINE,SYP OXICARBAMAZPINE,SYP BACLOFEN,TAB BRIVACETRAM 100MG,TAB BRIVACETRAM 75 MG,TA | |
| L5 | KASHMIR PHARMA & SURGICALS (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : TAB OXICARBAMAZPINE,SYP OXICARBAMAZPINE,SYP BACLOFEN,TAB BRIVACETRAM 100MG,TAB BRIVACETRAM 75 MG,TA |
Key insights about JAMMU AND KASHMIR tender market
The eligibility requirements include being a registered entity with a minimum average annual turnover of 3 Lakh. Bidders must provide documentation such as experience criteria, OEM authorization certificates, and evidence of past performance. Additionally, Micro, Small, and Medium Enterprises (MSEs) are eligible for exemptions related to experience and turnover.
Bidders must provide various certificates including an OEM authorization certificate, evidence proving previous past performance, and other certificates as specified in the Additional Terms and Conditions (ATC) of the tender. All documents must adhere to the approval criteria outlined in the tender documentation.
Interested bidders must register on the official procurement portal. This involves filling out required forms, verifying their registration status, and ensuring compliance with the stipulated eligibility requirements. Detailed instructions and links for registration can be found in the tender document.
Documents must be submitted in the prescribed formats as mentioned in the tender guidelines. This typically includes popular formats such as PDF, DOCX, and JPEG for supporting images or licenses. It is crucial to verify the submission guidelines to avoid disqualification.
Bidders need to provide products that meet specific technical specifications related to quality and safety as outlined in the tender. This includes documentation supporting compliance with industry standards for pharmaceuticals.
Yes, bidders must adhere to the relevant quality standards specific to pharmaceuticals, ensuring that all products purchased meet health and safety requirements mandated by regulatory bodies.
Bidders must comply with local regulations concerning product safety, quality control, and other parameters as specified in the tender documentation. This includes certifications proving adherence to health regulations.
The EMD is required as a form of security to ensure commitment to the bidding process. Specific amounts and acceptable payment methods are outlined within the tender document.
Bidders who are awarded the contract will be required to present a performance security deposit to ensure compliance with the contractual obligations. This amount is also detailed in the tender documentation.
Payment terms for winning bidders will be outlined in the contract post-selection, with details typically involving milestones related to delivery and acceptance of goods specified in the tender.
The price evaluation is based on a total value wise approach, which assesses not only the base price but also considers various conditions or terms outlined in the submission, ensuring that the most competitive and compliant bid prevails.
Bids must be submitted electronically through the designated procurement platform. All supporting documents will also need to be uploaded in the specified formats to enable complete evaluation.
Notifications regarding the results of the evaluation process will be communicated to the participating bidders through the procurement portal. It's essential to monitor the portal for updates regarding the outcomes.
MSEs can benefit from relaxed eligibility criteria in terms of experience and turnover. This encouragement aims to promote equal opportunities for smaller firms in the procurement process.
Startups may also avail special provisions similar to those offered to MSEs, ensuring enhanced participation opportunities within the procurement framework established by the Ministry.
The tender supports 'Make in India' initiatives by prioritizing local sourcing and encouraging domestic manufacturing of the required pharmaceutical products, contributing to national economic growth.
Local content and procurement rules necessitate that bidders demonstrate compliance with sourcing guidelines, prioritizing locally manufactured products and suppliers wherever feasible.
This extensive FAQ section is designed to provide clarity on the tender process and stimulate informed participation, promoting transparency and efficiency.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS